SCOPUS 정보 검색 플랫폼

Journal of Urology

Volumn 165, Issue 1, 2001, Pages 65-66

Editorial: New trends for optimal management of bladder tumors

(1) Pfister, Christian a

a ROUEN UNIVERSITY HOSPITAL (France)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; FLUOROURACIL; ANTINEOPLASTIC AGENT;

BLADDER CANCER; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RESEARCH; CANCER SURGERY; HUMAN; MEDICAL RESEARCH; PRIORITY JOURNAL; REVIEW; BLADDER TUMOR; CANCER INVASION; CARCINOMA IN SITU; CYSTECTOMY; MORTALITY; MULTIMODALITY CANCER THERAPY; NOTE; RADIATION DOSE; TRANSITIONAL CELL CARCINOMA;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA IN SITU; CARCINOMA, TRANSITIONAL CELL; COMBINED MODALITY THERAPY; CYSTECTOMY; HUMANS; NEOPLASM INVASIVENESS; RADIOTHERAPY DOSAGE; URINARY BLADDER NEOPLASMS;

EID: 0035234152 PISSN: 00225347 EISSN: None Source Type: Journal
DOI: 10.1097/00005392-200101000-00016 Document Type: Editorial

Times cited : (4)

References (13)

1
- 0019939964
- Mode of presentation of invasive bladder cancer: Reassessment of the problem
- (1982) J Urol , vol.128 , pp. 31
- Kaye, K.W.¹ Lange, P.H.²

2
- 0020579673
- Invasive bladder cancer: Support for screening
- (1983) J Urol , vol.130 , pp. 61
- Hopkins, C.S.¹ Ford, S.K.² Soloway, M.S.³

3
- 0032874431
- Immunocyt: A new tool for detecting transitional cell cancer of the urinary tract
- (1999) J Urol , vol.161 , pp. 1486
- Mian, C.¹ Pycha, A.² Wiener, H.³

4
- 0031953814
- p53 and Rb expression predict progression in T1 bladder cancer
- (1998) Clin Cancer Res , vol.4 , pp. 829
- Grossman, H.B.¹ Liebert, M.² Antelo, M.³

5
- 0033960423
- A critical analysis of the use of p53 as a marker for management of bladder cancer
- (2000) Urol Clin North Am , vol.27 , pp. 75
- Olumi, A.F.¹

6
- 0027452436
- Combined radiation and chemotherapy for invasive transitional-cell carcinoma of the bladder: A prospective study
- (1993) J Clin Oncol , vol.11 , pp. 2150
- Housset, M.¹ Maulard, C.² Chretien, Y.³

7
- 0027221462
- Combined modality program with possible organ preservation for invasive bladder carcinoma: Results of RTOG protocol 85-12
- (1993) Int of Radiat Oncol Biol Phys , vol.25 , pp. 783
- Tester, W.¹ Porter, A.² Asbell, S.³

8
- 0029843109
- Concurrent cisplatin and radiotherapy for patients with muscle invasive bladder cancer who are not candidates for radical cystectomy
- (1996) J Urol , vol.156 , pp. 1258
- Chauvet, B.¹ Brewer, Y.² Felix-Faure, C.³

9
- 0033951911
- Biological markers in superficial bladder tumors and their prognostic significance
- (2000) Urol Clin North Am , vol.27 , pp. 179
- Zlotta, A.R.¹ Schulman, C.C.²

10
- 0032845610
- Selective detection of inactivating mutations of the tumor suppressor gene p53 in bladder tumors
- (1999) J Urol , vol.161 , pp. 1973
- Pfister, C.¹ Flaman, J.M.² Martin, C.³

11
- 0030320521
- Analysis of p21WAF1/CIP1 in primary bladder tumors
- (1996) Oncol Res , vol.8 , pp. 409
- Lacombe, L.¹ Orlow, I.² Silver, D.³

12
- 0032527133
- Effect of p21WAF1/CIP1 expression on tumor progression in bladder cancer
- (1998) J Natl Cancer Inst , vol.90 , pp. 1072
- Stein, J.P.¹ Ginsberg, D.A.² Grossfeld, G.D.³

13
- 0034688223
- Tumorigenic pathways in low-stage bladder cancer based on p53, MDM2 and p21 phenotypes
- (2000) Int J Cancer , vol.89 , pp. 100
- Pfister, C.¹ Larue, H.² Moore, L.³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.